Vertex Pharmaceuticals Net Income Quarterly:
-308.02M for Dec. 31, 2012Vertex Pharmaceuticals Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -308.02M |
| Dec. 31, 2012 | -76.15M |
| Sept. 30, 2012 | -57.54M |
| June 30, 2012 | -64.93M |
| March 31, 2012 | 91.59M |
| Dec. 31, 2011 | 158.63M |
| Sept. 30, 2011 | 221.11M |
| June 30, 2011 | -174.07M |
| March 31, 2011 | -176.10M |
| Dec. 31, 2010 | -180.39M |
| Sept. 30, 2010 | -208.96M |
| June 30, 2010 | -200.01M |
| March 31, 2010 | -165.27M |
| Dec. 31, 2009 | -158.64M |
| Sept. 30, 2009 | -149.56M |
| June 30, 2009 | -171.30M |
| March 31, 2009 | -162.67M |
| Dec. 31, 2008 | -142.33M |
| Sept. 30, 2008 | -130.04M |
| June 30, 2008 | -91.32M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
VRTX Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| Cleveland BioLabs | 3.110M |
| Gilead Sciences | 722.19M |
| Merck | 1.593B |
VRTX Net Income Quarterly Rankings
| Overall |
31st percentile 5514 of 8002 |
| Sector |
5th percentile 647 of 684 in Healthcare |
| Industry |
7th percentile 230 of 248 in Biotechnology |
VRTX Net Income Quarterly Range, Past 5 Years
| Minimum | -308.02M | Mar 2013 |
| Maximum | 221.11M | Sep 2011 |
| Average | -107.30M |
